需三种血管加压药的脓毒性休克:患者人口学特征与结局
该多中心回顾性队列纳入MIMIC-IV与eICU-CRD两个ICU数据库(342个ICU、超过40万例)中年龄≥18岁、ICU期间至少同时使用3种血管加压药≥2小时且符合Sepsis-3脓毒症标准的患者,共3447例。中位年龄67岁,60.5%为男性,启动第三种升压药时96.6%为全复苏(full code)医嘱。需≥3种血管加压药的脓毒性休克院内死亡率为57.6%,启动第三种升压药后23.9%患者发生复苏意愿变更。基于MIMIC-IV分析,入ICU时乳酸升高(OR 2.79,95%CI 2.73-2.85)、入ICU至启动第三种升压药时间延长(OR 1.78,95%CI 1.69-1.87)、血清肌酐升高(OR 1.61,95%CI 1.59-1.62)及年龄>60岁(OR 1.47,95%CI 1.41-1.54)与死亡风险独立相关;非白人种族与Richmond躁动-镇静量表评分与死亡率无关。
要点
- 需≥3种血管加压药的脓毒性休克患者院内死亡率为57.6%。
- 启动第三种血管加压药后23.9%患者发生复苏意愿变更;启动时96.6%为全复苏医嘱。
- MIMIC-IV分析中入ICU乳酸升高与死亡独立相关(OR 2.79,95%CI 2.73-2.85)。
- 入ICU至启动第三种升压药时间延长(OR 1.78,95%CI 1.69-1.87)及肌酐升高(OR 1.61,95%CI 1.59-1.62)与死亡独立相关。
- 年龄>60岁与死亡独立相关(OR 1.47,95%CI 1.41-1.54);非白人种族与RASS评分与死亡率无关。
适用人群与场景
- 年龄≥18岁、收入任一ICU、ICU期间任何时间至少使用3种血管加压药≥2小时、且符合Sepsis-3脓毒症标准的患者。
- 数据来自MIMIC-IV与eICU-CRD两个ICU数据库,共342个ICU、超过40万例患者。
诊断标准与关键阈值
- 脓毒症诊断采用Sepsis-3标准。
- 纳入条件为ICU期间任何时间至少使用3种血管加压药持续至少2小时。
研究设计与关键结果
- 多中心回顾性队列,纳入MIMIC-IV与eICU-CRD两个ICU数据库(342个ICU、超过40万例),共3447例符合纳入标准。
- 中位年龄67岁,60.5%为男性,启动第三种血管加压药时96.6%为全复苏医嘱。
- 需≥3种血管加压药的脓毒性休克院内死亡率为57.6%。
- 启动第三种血管加压药后23.9%患者发生复苏意愿变更。
- 基于MIMIC-IV数据库分析,入ICU时乳酸升高(OR 2.79,95%CI 2.73-2.85)、入ICU至启动第三种升压药时间延长(OR 1.78,95%CI 1.69-1.87)、血清肌酐升高(OR 1.61,95%CI 1.59-1.62)、年龄>60岁(OR 1.47,95%CI 1.41-1.54)与死亡风险独立相关。
- 非白人种族与Richmond躁动-镇静量表评分与死亡率无关。
证据类型、等级与局限
- 证据类型:多中心回顾性队列研究(基于MIMIC-IV与eICU-CRD两个ICU数据库)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,了解该人群死亡风险最高的患者特征,可能有助于管理及在共同决策中传达预期。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Septic shock is a common condition necessitating timely management including hemodynamic support with vasopressors. Despite the high prevalence and mortality, there is limited data characterizing patients who require three or more vasopressors. We sought to define the demographics, outcomes, and prognostic determinants associated with septic shock requiring three or more vasopressors.
DESIGN: This is a multicenter retrospective cohort of two ICU databases, Medical Information Mart for Intensive Care IV (MIMIC-IV) and electronic ICU-Clinical Research Database, which include over 400,000 patients admitted to 342 ICUs.
PATIENTS: Inclusion criteria entailed patients who were: 1) age 18 years old and older, 2) admitted to any ICU, 3) administered at least three vasopressors for at least 2 hours at any time during their ICU stay, and 4) identified to have sepsis based on the Sepsis-3 criteria.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: A total of 3447 patients met inclusion criteria. The median age was 67 years, 60.5% were male, and 96.6% had full code orders at the time of the third vasopressor initiation. Septic shock requiring three or more vasopressors was associated with 57.6% in-hospital mortality. Code status changes occurred in 23.9% of patients following initiation of a third vasopressor. Elevated lactate upon ICU admission (odds ratio [95% CI], 2.79 [2.73-2.85]), increased duration of time between ICU admission and third vasopressor initiation (1.78 [1.69-1.87]), increased serum creatinine (1.61 [1.59-1.62]), and age above 60 years (1.47 [1.41-1.54]) were independently associated with an increased risk of mortality based on analysis of the MIMIC-IV database. Non-White race and Richmond Agitation-Sedation Scale scores were not associated with mortality.
CONCLUSIONS: Septic shock requiring three vasopressors is associated with exceptionally high mortality. Knowledge of patients at highest risk of mortality in this population may inform management and expectations conveyed in shared decision-making.
参考来源
- Kwak GH, Madushani RWMA, Adhikari L, et al. Septic Shock Requiring Three Vasopressors: Patient Demographics and Outcomes. Crit Care Explor. 2024. PMID: 39513987. doi:10.1097/CCE.0000000000001167
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。